Researchers target pancreatic cancer with bioengineered "construct"

10/14/2009 | Atlanta Journal-Constitution, The

U.S. scientists are testing the effectiveness of a bioengineered "construct" that uses stem cells derived from bone marrow and a genetic product that halts tumor progression in targeting pancreatic cancer without causing harm to healthy tissue. The treatment, which is in preliminary development, works by confusing and inducing tumor cells to produce a toxic product.

View Full Article in:

Atlanta Journal-Constitution, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI